Return to Issue Details The Limits of a Reporting Baseline: Sex Differences in Adverse Event Reporting for Tumour Necrosis Factor Blockers, GLP-1 Receptor Agonists and Proton Pump Inhibitors Across 1,753,642 Reports Download Download PDF